Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1
Web of Science
AuthorFoletta, VC; Lim, MA; Soosairaiah, J; Kelly, AP; Stanley, EG; Shannon, M; He, W; Das, S; Massague, J; Bernard, O
Source TitleThe Journal of Cell Biology
PublisherROCKEFELLER UNIV PRESS
University of Melbourne Author/sStanley, Edouard
Document TypeJournal Article
CitationsFoletta, V. C., Lim, M. A., Soosairaiah, J., Kelly, A. P., Stanley, E. G., Shannon, M., He, W., Das, S., Massague, J. & Bernard, O. (2003). Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. JOURNAL OF CELL BIOLOGY, 162 (6), pp.1089-1098. https://doi.org/10.1083/jcb.200212060.
Access StatusOpen Access
Bone morphogenetic proteins (BMPs) regulate multiple cellular processes, including cell differentiation and migration. Their signals are transduced by the kinase receptors BMPR-I and BMPR-II, leading to Smad transcription factor activation via BMPR-I. LIM kinase (LIMK) 1 is a key regulator of actin dynamics as it phosphorylates and inactivates cofilin, an actin depolymerizing factor. During a search for LIMK1-interacting proteins, we isolated clones encompassing the tail region of BMPR-II. Although the BMPR-II tail is not involved in BMP signaling via Smad proteins, mutations truncating this domain are present in patients with primary pulmonary hypertension (PPH). Further analysis revealed that the interaction between LIMK1 and BMPR-II inhibited LIMK1's ability to phosphorylate cofilin, which could then be alleviated by addition of BMP4. A BMPR-II mutant containing the smallest COOH-terminal truncation described in PPH failed to bind or inhibit LIMK1. This study identifies the first function of the BMPR-II tail domain and suggests that the deregulation of actin dynamics may contribute to the etiology of PPH.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References